Assessing the safety of immunologic modifiers for the treatment of chronic disease: the psoriasis paradigm.
Stern
Robert S
RS
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology*
D000276:Adjuvants, Immunologic